← Back to Search

Exercise and diet education and instruction for Gynecologic Cancers

N/A
Waitlist Available
Led By Angela J Fong, PhD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are not active, defined as engaging in < 150 minutes of moderate-to-vigorous physical activity per week
Have a potential unhealthy diet, defined as consuming < 2.5 servings of fruits and vegetables per day, or fast foods more than once per week over the past month
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 13
Awards & highlights

Study Summary

This trial will test a 12-week health behavior change intervention for feasibility and acceptability. The intervention will be guided by the MOST framework, which uses efficient experiments to test and compare the effects of different components of the intervention. The goal of the MOST framework is to balance effectiveness with affordability, sustainability, and efficiency.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are not physically active enough, meaning you engage in less than 150 minutes of moderate-to-vigorous physical activity per week.
Select...
You have been eating a lot of fast food or not enough fruits and vegetables recently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 13
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 13 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability
Participant attendance
Participant retention
Secondary outcome measures
6-minute walk test (m)
Arm curl test (quantity)
Blood pressure
+13 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Exercise and diet education and instructionExperimental Treatment1 Intervention
The intervention will be 12 weeks in duration. The five intervention components (e.g., educational sessions and instructional sessions) will be supervised. Research staff will conduct the intervention. Participants will be instructed to gradually aim for 30 minutes of physical activity for five days per week by Week 12 Participants will also aim for improved healthy dietary practices including > 200 grams/day (g/d) of fruits and vegetables, > 15 g/d of fiber (whole grains and beans), < 250 g/d of sugar-sweetened drinks and lower percent of total kcal from fast foods18 by Week 12. Sessions will be about 35- to 50-minutes in duration and be structured as follows: (a) review of previous session and an opportunity to ask questions (~5 minutes); (b) presentation of content (20- to 30-minutes); (c) opportunity for questions (~5 minutes); and (d) preview of next sessions and research activity reminders (2- to 3-minutes).

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
424 Previous Clinical Trials
64,133 Total Patients Enrolled
2 Trials studying Gynecologic Cancers
405 Patients Enrolled for Gynecologic Cancers
Angela J Fong, PhDPrincipal InvestigatorRutgers Cancer Institute of New Jersey

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the expected results from this scientific experiment?

"This 13-week experiment seeks to measure acceptability as the primary outcome. Subsequent objectives are quantifying exercise self-efficacy with an adapted scale, assessing upper body strength via arm curl tests, and gauging physical activity intensity/duration with a modified Godin Shephard survey."

Answered by AI

Is there currently an opportunity for individuals to participate in this medical trial?

"According to clinicaltrials.gov, this medical study is not currently recruiting participants; it was first advertised on November 1st 2022 and last modified on October 11th 2022. Although there are no active recruitment efforts for this trial at present, 72 alternative trials can presently accommodate patients."

Answered by AI
~0 spots leftby Mar 2025